Co-Diagnostics Current Ratio 2017-2024 | CODX

Co-Diagnostics current ratio from 2017 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Co-Diagnostics Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2024-03-31 $0.05B $0.01B 10.19
2023-12-31 $0.06B $0.01B 10.81
2023-09-30 $0.07B $0.01B 13.99
2023-06-30 $0.08B $0.01B 15.13
2023-03-31 $0.09B $0.00B 23.80
2022-12-31 $0.09B $0.00B 23.94
2022-09-30 $0.10B $0.01B 16.95
2022-06-30 $0.12B $0.01B 17.06
2022-03-31 $0.13B $0.01B 9.63
2021-12-31 $0.12B $0.01B 9.14
2021-09-30 $0.10B $0.00B 24.83
2021-06-30 $0.09B $0.01B 19.10
2021-03-31 $0.08B $0.00B 18.38
2020-12-31 $0.07B $0.00B 16.69
2020-09-30 $0.05B $0.00B 28.63
2020-06-30 $0.04B $0.00B 12.36
2020-03-31 $0.02B $0.00B 16.43
2019-12-31 $0.00B $0.00B 4.83
2019-09-30 $0.00B $0.00B 10.02
2019-06-30 $0.01B $0.00B 14.61
2019-03-31 $0.01B $0.00B 16.53
2018-12-31 $0.00B $0.00B 0.45
2018-09-30 $0.00B $0.00B 1.09
2018-06-30 $0.00B $0.00B 6.13
2018-03-31 $0.00B $0.00B 10.98
2017-12-31 $0.00B $0.00B 7.09
2017-09-30 $0.01B $0.00B 8.73
2017-06-30 $0.00B $0.01B 0.07
2017-03-31 $0.00B 0.00
2016-12-31 $0.00B 0.00
2016-09-30 $0.00B 0.00
2016-06-30 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical Services $0.050B $0.007B
Co-Diagnostics Inc. is a molecular diagnostics company. It develops, manufactures and markets a new, state-of-the-art diagnostics technology. The Company's technology is utilized for tests which are designed using the detection and/or analysis of nucleic acid molecules. It also uses proprietary technology to design specific tests to locate genetic markers for use in industries other than infectious disease and license the use of those tests to specific customers. Co-Diagnostics Inc. is based in UT, United States.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $124.299B 15.60
Cencora (COR) United States $46.379B 18.08
ICON (ICLR) Ireland $25.848B 24.40
DiDi Global (DIDIY) China $20.706B 0.00
Avantor (AVTR) United States $14.726B 21.68
CochLear (CHEOY) Australia $13.973B 0.00
Natera (NTRA) United States $13.533B 0.00
Revvity (RVTY) United States $13.407B 23.52
Medpace Holdings (MEDP) United States $12.205B 40.15
Viatris (VTRS) United States $12.109B 3.62
EUROFINS SCIENT (ERFSF) Luxembourg $10.989B 0.00
Charles River Laboratories (CRL) United States $10.790B 20.66
Solventum (SOLV) United States $9.423B 0.00
Sonic Healthcare (SKHHY) Australia $7.951B 0.00
HealthEquity (HQY) United States $7.177B 46.08
Doximity (DOCS) United States $5.537B 38.78
Bausch + Lomb (BLCO) Canada $5.309B 21.25
Organon (OGN) United States $5.246B 4.98
PACS (PACS) United States $4.392B 0.00
Life Times (LTH) United States $3.563B 37.33
Sotera Health (SHC) United States $3.281B 16.10
GoodRx Holdings (GDRX) United States $3.193B 121.57
Surgery Partners (SGRY) United States $3.177B 29.07
Agilon Health (AGL) United States $2.838B 0.00
Progyny (PGNY) United States $2.569B 44.23
NovoCure (NVCR) Jersey $2.296B 0.00
AMN Healthcare Services Inc (AMN) United States $2.102B 8.33
Premier (PINC) United States $1.927B 8.24
BrightSpring Health Services (BTSG) United States $1.794B 0.00
Teladoc Health (TDOC) United States $1.696B 0.00
Alignment Healthcare (ALHC) United States $1.591B 0.00
Ryman Healthcare (RYHTY) New Zealand $1.566B 0.00
Establishment Labs Holdings (ESTA) $1.224B 0.00
GeneDx Holdings (WGS) United States $0.752B 0.00
CareDx (CDNA) United States $0.739B 0.00
Embecta (EMBC) United States $0.738B 5.02
InnovAge Holding (INNV) United States $0.691B 0.00
Pediatrix Medical (MD) United States $0.609B 6.46
Auna S.A (AUNA) Luxembourg $0.600B 0.00
QDM (QDMI) Hong Kong, SAR China $0.583B 15.27
COMPASS Pathways (CMPS) United Kingdom $0.455B 0.00
Enhabit (EHAB) United States $0.441B 44.00
ModivCare (MODV) United States $0.375B 7.02
Sonida Senior Living (SNDA) United States $0.369B 0.00
LifeMD (LFMD) United States $0.329B 0.00
DocGo (DCGO) United States $0.294B 16.06
Sharecare (SHCR) United States $0.292B 0.00
MultiPlan (MPLN) United States $0.281B 0.00
Sera Prognostics (SERA) United States $0.261B 0.00
Beauty Health (SKIN) United States $0.244B 0.00
Ascend Wellness Holdings (AAWH) United States $0.196B 0.00
Biodesix (BDSX) United States $0.184B 0.00
So-Young (SY) China $0.114B 55.25
Pono Capital Two (PTWO) United States $0.072B 0.00
NeueHealth (NEUE) United States $0.044B 5.99
IceCure Medical (ICCM) Israel $0.037B 0.00
Oncology Institute (TOI) United States $0.034B 0.00
Nutex Health (NUTX) United States $0.027B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.027B 0.00
BIMI Holdings (BIMI) United States $0.024B 0.00
Singular Genomics Systems (OMIC) United States $0.024B 0.00
OncoCyte (OCX) United States $0.023B 0.00
KindlyMD (KDLY) $0.016B 0.00
SeaStar Medical Holding (ICU) United States $0.012B 0.00
DermTech (DMTK) United States $0.011B 0.00
XWELL (XWEL) United States $0.011B 0.00
TRxADE HEALTH (MEDS) United States $0.009B 0.00
BioNexus Gene Lab (BGLC) $0.008B 0.00
ISpecimen (ISPC) United States $0.007B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
NewGenIvf Group (NIVF) Singapore $0.004B 0.00
OpGen (OPGN) United States $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00
Assure Holdings (IONM) United States $0.002B 0.00